'Autoimmunity' is not always associated with prolonged survival in melanoma patients

British Journal of Dermatology

Volumn 159, Issue 3, 2008, Pages 735-736

  Pfohler C ^a   Schmaltz, R ^a   Graeber, S ^a   Tilgen, W ^a  

^a SAARLAND UNIVERSITY   (Germany)

Author keywords

Antibodies; Autoimmunity; Melanoma; Survival

Indexed keywords

ALPHA INTERFERON; AUTOANTIBODY; DACARBAZINE; THYROID ANTIBODY;

ADJUVANT THERAPY; AUTOIMMUNE THYROIDITIS; AUTOIMMUNITY; CANCER STAGING; CANCER SURVIVAL; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOTHERAPY; LETTER; LOW DRUG DOSE; MELANOMA; OVERALL SURVIVAL; PRIORITY JOURNAL; RETINA;

ANTIBODIES; AUTOIMMUNITY; BIOLOGICAL MARKERS; HUMANS; MELANOMA; RETINA; SKIN NEOPLASMS; SURVIVAL RATE;

EID: 49749114899     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2008.08675.x     Document Type: Letter

References (5)

1. Satzger I, Meier A, Schenck F et al. Autoimmunity as a prognostic factor in melanoma patients treated with adjuvant low-dose interferon alpha. Int J Cancer 2007 121 : 2562 6.
2. Gogas H, Ioannovich J, Dafni U et al. Prognostic significance of autoimmunity during treatment of melanoma with interferon. N Engl J Med 2006 16 : 709 18.
3. Ladewig G, Reinhold U, Thirkill CE et al. Incidence of antiretinal antibodies in melanoma: screening of 77 serum samples from 51 patients with American Joint Committee on Cancer stage I-IV. Br J Dermatol 2005 152 : 931 8.
4. Keltner JL, Thirkill CE, Yip PT. Clinical and immunologic characteristics of melanoma-associated retinopathy syndrome: eleven new cases and a review of 51 previously published cases. J Neuroophthalmol 2001 21 : 173 87.
5. Vercambre-Darras S, Dubucquoi S, Fajardy I et al. Does spontaneous autoimmunity improve survival in visceral metastatic melanoma? Br J Dermatol 2007 157 : 413 15.